Madrid, Spain, and Heidelberg, Germany, November 18, 2016 – SYGNIS AG (Frankfurt: LIO1; ISIN: DE000A1RFM03; Prime Standard) today announced the attendance at two major German investor conferences in November and December 2016.
German Equity Forum hosted by Deutsche Börse AG
Date of attendance: 21 and 22 November 2016
Presentation time: Monday, 21 November 2016, 17:00 - 17:30 pm CET, Room Oslo
Venue: Frankfurt/Main, Germany, Sheraton Frankfurt Airport Hotel and Conference Center
Presenting and available for meetings: Dr. Heikki Lanckriet, Co-CEO and CSO, Pilar de la Huerta, Co-CEO/CFO
More information: http://www.eigenkapitalforum.com/
22nd Munich Capital Markets Conference (MKK) hosted by GBC AG
Date of attendance: 7 and 8 December 2016
Presentation time: Tuesday, 7 December 2016, 12:20 - 13:00 pm CET, Room GBC III
Venue: Munich, Germany, The Charles Hotel
Presenting and available for meetings: Dr. Heikki Lanckriet, Co-CEO and CSO, Pilar de la Huerta, CEO/CFO
More information: http://www.mkk-investor.de/
If you would like to meet us, please contact for both conferences: contact@mc-services.eu or via phone: +49 89 210 228-0.
For further information, please contact:
SYGNIS AG
Pilar de la Huerta
Co-CEO/CFO
Phone: +34 91 192 36 50
Email: pdelahuerta@sygnis.com
MC Services AG
Raimund Gabriel
Managing Partner
Phone: +49 89 210228 0
Email: raimund.gabriel@mc-services.eu
About SYGNIS AG: www.sygnis.com
SYGNIS AG is specialized in the development and the commercialization of proprietary technologies and offers a wide range of different commercial products addressing key challenges in molecular biology. With the acquisition of Expedeon Holdings, Ltd. based in Cambridge, UK, SYGNIS has added a complementary proteomic product portfolio. Resulting from this significant expansion, SYGNIS’ product portfolio now covers the entire workflow of molecular biology. The products are sold through a direct sales force and several distribution partners in Europe, the US and Asia. SYGNIS AG has offices in Germany, Spain and the UK, production sites in the UK and the US as well as sales offices in Asia. The company is listed on the German Stock Exchange in Frankfurt in the Prime Standard segment (Ticker: LIO1; ISIN: DE000A1RFM03).
